OFEV® (nintedanib) time to face IPF head on A broad ILD patient base that can benefit Document ID: PC-ZA-102088 13/06/2023 Author: Boehringer Ingelheim Progressive phenotype in SSc-ILD patients RELATED CONTENT PC-ZA-102088 Production date: June 2023
